{"id":"https://openalex.org/W2609753980","doi":"https://doi.org/10.1111/bjh.14705","title":"Leucocyte and eosinophil counts predict progression\u2010free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD 1 inhibition","display_name":"Leucocyte and eosinophil counts predict progression\u2010free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD 1 inhibition","publication_year":2017,"publication_date":"2017-04-25","ids":{"openalex":"https://openalex.org/W2609753980","doi":"https://doi.org/10.1111/bjh.14705","mag":"2609753980","pmid":"https://pubmed.ncbi.nlm.nih.gov/28439879"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.14705","doi":"https://doi.org/10.1111/bjh.14705","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14705","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14705","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14705","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085373822","display_name":"Ida Hude","orcid":"https://orcid.org/0000-0001-5527-0647","observed_orcids":["https://orcid.org/0000-0001-5527-0647"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]},{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE","HR"],"is_corresponding":false,"raw_author_name":"Ida Hude","raw_affiliation_strings":["Department of Internal Medicine, Division of Haematology, University Hospital Centre Zagreb, Zagreb, Croatia","German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany"],"raw_orcid":"https://orcid.org/0000-0001-5527-0647","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Haematology, University Hospital Centre Zagreb, Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732"]},{"raw_affiliation_string":"German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059416243","display_name":"Stephanie Sasse","orcid":"https://orcid.org/0000-0002-1080-4606","observed_orcids":["https://orcid.org/0000-0002-1080-4606"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephanie Sasse","raw_affiliation_strings":["German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061291419","display_name":"Paul Jan Br\u00f6ckelmann","orcid":"https://orcid.org/0000-0001-9662-9900","observed_orcids":["https://orcid.org/0000-0001-9662-9900"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Paul J. Br\u00f6ckelmann","raw_affiliation_strings":["German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040054777","display_name":"Bastian von Tresckow","orcid":"https://orcid.org/0000-0003-1410-4487","observed_orcids":["https://orcid.org/0000-0003-1410-4487"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bastian von Tresckow","raw_affiliation_strings":["German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034359187","display_name":"Jesko Momotow","orcid":"https://orcid.org/0000-0002-0422-2458","observed_orcids":["https://orcid.org/0000-0002-0422-2458"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jesko Momotow","raw_affiliation_strings":["German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057387418","display_name":"Andreas Engert","orcid":"https://orcid.org/0000-0002-1890-1523","observed_orcids":["https://orcid.org/0000-0002-1890-1523"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Engert","raw_affiliation_strings":["German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072973570","display_name":"Sven Borchmann","orcid":"https://orcid.org/0000-0001-6662-6864","observed_orcids":["https://orcid.org/0000-0001-6662-6864"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Sven Borchmann","raw_affiliation_strings":["German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072973570"],"corresponding_institution_ids":["https://openalex.org/I4210153755"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":3.1398,"has_fulltext":true,"cited_by_count":31,"citation_normalized_percentile":{"value":0.92664396,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"181","issue":"6","first_page":"837","last_page":"840"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-hodgkin-lymphoma","display_name":"relapsed/refractory Hodgkin lymphoma","score":0.9290000200271606},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.8980000019073486},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9760000109672546},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6819999814033508},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7789999842643738},{"id":"https://openalex.org/keywords/differential-blood-count","display_name":"differential blood count","score":0.6830000281333923},{"id":"https://openalex.org/keywords/eosinophil-count","display_name":"eosinophil count","score":0.7789999842643738},{"id":"https://openalex.org/keywords/white-blood-cell-count","display_name":"white blood cell count","score":0.8069999814033508},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5979999899864197},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8740000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6782002449035645},{"id":"https://openalex.org/C2910914307","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Classical Hodgkin lymphoma","level":4,"score":0.6745045781135559},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6648578643798828},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6506057977676392},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.5904566049575806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5274921655654907},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.5188561677932739},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.447261780500412},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.443502277135849},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.4221956729888916},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36024636030197144},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.3491226136684418},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12273353338241577},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004804","descriptor_name":"Eosinophils","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007958","descriptor_name":"Leukocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D064592","descriptor_name":"Autografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bjh.14705","doi":"https://doi.org/10.1111/bjh.14705","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14705","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14705","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:28439879","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28439879","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Letter"},{"id":"pmh:oai:USBKOELN.ub.uni-koeln.de:18469","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/18469/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400371","display_name":"K\u00f6lner Universit\u00e4ts PublikationsServer (Universit\u00e4t zu K\u00f6ln)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115942","host_organization_name":"Rhenish Institute for Environmental Research","host_organization_lineage":["https://openalex.org/I4210115942"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"doc-type:article"}],"best_oa_location":{"id":"doi:10.1111/bjh.14705","doi":"https://doi.org/10.1111/bjh.14705","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14705","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14705","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320310646","display_name":"European Hematology Association","ror":"https://ror.org/05hk0hn26"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2609753980.pdf","grobid_xml":"https://content.openalex.org/works/W2609753980.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1968101362","https://openalex.org/W2036123202","https://openalex.org/W2037801848","https://openalex.org/W2125616358","https://openalex.org/W2133201432","https://openalex.org/W2282962877","https://openalex.org/W2328676772","https://openalex.org/W2397854274","https://openalex.org/W2473498748","https://openalex.org/W2504623699"],"related_works":["https://openalex.org/W2011450437","https://openalex.org/W2074118258","https://openalex.org/W2617947656","https://openalex.org/W2979971451","https://openalex.org/W2782094678","https://openalex.org/W2978163532","https://openalex.org/W2591671154","https://openalex.org/W2613433758","https://openalex.org/W3029854097","https://openalex.org/W4389043288"],"abstract_inverted_index":{"The":[0,128,637,905,949,1067,1208],"programmed":[1],"death-1":[2],"(PD1,":[3],"also":[4],"termed":[5],"PDCD1)":[6],"inhibitors":[7],"nivolumab":[8,106],"and":[9,45,81,113,150,204,235,265,276,343,365,392,408,422,430,451,484,496,517,534,567,587,616,699,730,764,932,1019,1072,1075,1089,1097,1103,1106,1113,1117,1119,1124,1143,1145,1156,1164,1183,1197,1199,1206],"pembrolizumab":[10],"have":[11,736,758],"recently":[12,829],"shown":[13],"remarkable":[14],"efficacy":[15,681],"in":[16,85,100,350,376,413,684,695,702,714,739,766,792,832,877,885,890,925,962,988,1025,1045,1049,1055,1085],"relapsed":[17],"or":[18,468,471,974],"refractory":[19],"(r/r)":[20],"classical":[21],"Hodgkin":[22,1031],"lymhoma":[23],"(cHL)":[24],"(Ansell":[25],"et":[26,30,34,167,708,745,770,774,786,837],"al,":[27,31,35,168,709,746,771,775,787,838],"2015;":[28],"Armand":[29],"2016;":[32,772],"Younes":[33],"2016).":[36,776],"Nevertheless,":[37,711,915],"not":[38,53,399,595,718,1082,1091],"all":[39,277],"patients":[40,88,103,245,262,270,297,462,579,603,621,729,768,889,920,931,961,1053,1116],"respond":[41],"to":[42,62,68,133,143,155,190,491,554,575,660,856,883,895,908,964,1016,1140],"this":[43,670,947,1046],"treatment":[44,275,592],"the":[46,70,91,137,144,156,177,192,201,210,304,315,319,329,357,366,381,486,510,514,558,576,655,661,672,703,740,749,805,817,861,878,891,993,1029,1063,1070,1086,1100,1108,1131],"risk":[47,193,527,541,642,663,872,880],"of":[48,58,72,122,147,194,243,250,259,307,318,479,488,528,583,601,607,619,625,682,742,782,804,819,852,930,934,951,959,986,999,1062,1214],"immune-related":[49],"adverse":[50,692],"events":[51],"is":[52,671,700,724,810,938],"negligible.":[54],"Consequently,":[55],"predictive":[56],"biomarkers":[57,954],"PD1":[59],"inhibition":[60,752,990],"need":[61],"be":[63,844,944],"identified.":[64],"This":[65],"study":[66,674,1047,1088],"aimed":[67],"examine":[69],"association":[71],"differential":[73,129],"blood":[74,130,321,722],"count":[75,131,323,332,336,340,345],"parameters":[76],"at":[77,107,119,176,291],"baseline":[78,754],"with":[79,90,105,216,246,280,465,524,538,604,622,762,922,967,971,1028,1060],"response":[80,135,181,657,763,807,827],"progression-free":[82],"survival":[83,205,765],"(PFS)":[84],"r/r":[86,101,715,918],"cHL":[87,102,698,716,728,743,853,919],"treated":[89,104,279,921,1054],"anti-PD1":[92,923],"antibody,":[93],"nivolumab.":[94,148],"We":[95,313,403,473,794],"performed":[96,140,199],"a":[97,120,247,351,414,466,494,497,519,535,539,551,581,605,623,676,737,790,823,833,845,849,902,926,982,996,1022,1038,1056],"retrospective":[98],"analysis":[99,197],"our":[108,480,668,865],"department":[109],"between":[110,493],"September":[111,114],"2014":[112],"2016.":[115],"Nivolumab":[116],"was":[117,136,188,198,231,310,522,1048,1081],"administered":[118],"dose":[121,146,282],"3":[123,641],"mg/kg":[124],"every":[125],"2":[126,626],"weeks.":[127],"used":[132,189,485],"predict":[134,191],"last":[138,178],"one":[139,589],"immediately":[141],"prior":[142,300,308],"first":[145,673],"Response":[149],"PFS":[151,349,375,556,594,910],"were":[152,174,207,214,256,263,278,372,398],"defined":[153],"according":[154,659],"revised":[157],"2007":[158],"International":[159,704],"Working":[160],"Group":[161],"criteria":[162],"for":[163,222,348,374,401,504,507,542,644,848,874,995,1013],"Malignant":[164],"Lymphoma":[165],"(Cheson":[166],"2007).":[169],"Patients":[170,876],"without":[171],"disease":[172],"progression":[173,529,543,645],"censored":[175],"available":[179,953],"radiological":[180],"assessment.":[182],"A":[183,228,241],"Cox":[184,352],"proportional":[185,353],"hazards":[186,354],"model":[187,416,512,835,868],"progression.":[195],"Survival":[196],"per":[200],"Kaplan-Meier":[202],"method":[203],"curves":[206],"compared":[208],"using":[209,557],"logrank":[211],"test.":[212],"Analyses":[213],"done":[215],"R":[217],"version":[218],"3.3.1":[219],"(R":[220],"Foundation":[221],"Statistical":[223],"Computing,":[224],"Vienna,":[225],"Austria.":[226],"http://www.R-project.org/).":[227],"P-value":[229],"<0\u00b705":[230],"considered":[232],"statistically":[233],"significant":[234],"95%":[236],"confidence":[237],"intervals":[238],"are":[239],"shown.":[240],"total":[242],"30":[244,260],"median":[248,305,487],"age":[249],"37":[251],"years":[252],"[Interquartile":[253],"range:":[254],"28\u201344]":[255],"included.":[257],"Eighteen":[258],"(60%)":[261],"male":[264],"12":[266],"(40%)":[267],"female.":[268],"All":[269,1127],"had":[271,298,580],"received":[272,299,1003,1035],"appropriate":[273],"first-line":[274],"high":[281,467,495,520,536],"chemotherapy":[283],"followed":[284],"by":[285,812,1148],"autologous":[286],"stem":[287],"cell":[288,322],"transplant":[289],"(ASCT)":[290],"relapse.":[292],"In":[293,379,509,651,748],"total,":[294],"21":[295],"(70\u00b70%)":[296],"brentuximab":[301],"vedotin":[302],"(BV);":[303],"number":[306],"treatments":[309],"5":[311,599],"(2\u201311).":[312],"tested":[314,559],"prognostic":[316,373,400,411,438,693,867],"value":[317,412],"white":[320],"(WBC,":[324],"\u00d7109/l),":[325],"as":[326,328,690,780,802,1021],"well":[327],"relative":[330],"eosinophil":[331,756],"(REC,":[333],"%),":[334,338],"neutrophil":[335],"(RNC,":[337],"monocyte":[339],"(RMC,":[341],"%)":[342,347],"lymphocyte":[344],"(RLC,":[346],"model.":[355,948],"Only":[356],"WBC":[358,407,425,470,516,521,562,686],"(hazard":[359],"ratio":[360],"(HR):":[361],"1\u00b7110":[362],"[1\u00b7024;":[363],"1\u00b7202])":[364],"REC":[367,409,431,537,568],"(HR:":[368,383,388,394,426,432,442,447,453,530,544],"0\u00b7469":[369],"[0\u00b7265;":[370],"0\u00b7828])":[371],"univariate":[377],"analysis.":[378],"contrast,":[380],"RNC":[382,441],"1\u00b7034":[384],"[0\u00b7991;":[385],"1\u00b7079]),":[386],"RMC":[387,421,446],"0\u00b7942":[389],"[0\u00b7850;":[390],"1\u00b7044])":[391],"RLC":[393,452],"0\u00b7973":[395],"[0\u00b7908;":[396],"1\u00b7043])":[397],"PFS.":[402,875],"subsequently":[404],"evaluated":[405,654],"if":[406],"retained":[410,436],"multivariate":[415],"including":[417,513],"WBC,":[418],"REC,":[419,518],"RNC,":[420],"RLC.":[423],"Indeed,":[424],"1\u00b7158":[427],"[1\u00b7026;":[428],"1\u00b7308])":[429],"0\u00b7398":[433],"[0\u00b7175;":[434],"0\u00b7905])":[435],"their":[437],"value,":[439,499],"whereas":[440,598,888],"1\u00b7218":[443],"[0\u00b7720;":[444],"2\u00b7062]),":[445],"1\u00b7372":[448],"[0\u00b7809;":[449],"2\u00b7326])":[450],"1\u00b7257":[454],"[0\u00b7708;":[455],"2\u00b7230])":[456],"remained":[457],"non-prognostic.":[458],"Next,":[459],"we":[460,549,653],"divided":[461],"into":[463,981],"those":[464,966],"low":[469,481,498,879],"REC.":[472,508],"avoided":[474],"optimizing":[475],"cut-off":[476,560,936],"values":[477,937],"because":[478],"case":[482],"numbers":[483],"both":[489],"variables":[490],"differentiate":[492],"i.e.,":[500],"7\u00b778":[501,564],"\u00d7":[502,565],"109/l":[503,566],"WBC;":[505],"1\u00b77%":[506,570],"final":[511],"dichotomized":[515],"associated":[523],"an":[525,691,799,1004,1137],"increased":[526],"5\u00b7151":[531],"[1\u00b7291;":[532],"20\u00b7550])":[533],"decreased":[540],"0\u00b7137":[545],"[0\u00b7027;":[546],"0\u00b7680]).":[547],"Finally,":[548],"constructed":[550],"simple":[552,677,866],"score":[553,582,606,624,638,664,678,906],"prognosticate":[555,909],"points:":[561],"\u2265":[563],"<":[569,647],"each":[571],"added":[572],"1":[573,608],"point":[574],"score.":[577],"Ten":[578],"0":[584],"(low":[585],"risk)":[586,610,628],"only":[588],"progressed":[590,629],"during":[591],"(median":[593,611,630],"available,":[596],"NA),":[597],"out":[600,618],"11":[602],"(intermediate":[609],"PFS:":[612,631],"365":[613],"[129-NA]":[614],"days)":[615],"7":[617],"9":[620],"(high":[627],"197":[632],"[50-NA]":[633],"days,":[634],"Fig":[635],"1).":[636,650,666],"clearly":[639],"differentiated":[640],"groups":[643,873],"(P":[646],"0\u00b7001)":[648],"(Fig":[649],"addition,":[652],"best":[656,913],"achieved":[658],"initial":[662],"(Table":[665],"To":[667],"knowledge,":[669],"presenting":[675],"that":[679,734,796],"predicts":[680],"PD1-inhibition":[683],"cHL.":[685],"has":[687,717,828],"been":[688,719,760,830],"recognized":[689],"marker":[694,847],"newly":[696],"diagnosed":[697],"included":[701],"Prognostic":[705],"Score":[706],"(Hasenclever":[707],"1998).":[710],"its":[712],"role":[713,738,791,801,985,1139],"established.":[720],"Peripheral":[721],"eosinophilia":[723,841],"frequently":[725],"observed":[726],"among":[727,917],"preclinical":[731],"data":[732,1078,1105],"suggests":[733],"eosinophils":[735,797,821,987],"pathobiology":[741],"(Aldinucci":[744],"2010).":[747],"immune":[750,806,813,857],"checkpoint":[751,814,858,989],"era,":[753],"peripheral":[755],"counts":[757],"already":[759],"correlated":[761],"melanoma":[767],"(Martens":[769],"Weide":[773],"Eosinophils":[777],"can":[778,943],"act":[779],"effectors":[781],"tumour":[783],"rejection":[784],"(Gatault":[785],"2012),":[788],"implicating":[789],"immunosurveillance.":[793],"hypothesize":[795],"play":[798],"active":[800],"co-effectors":[803],"once":[808],"it":[809],"reinstated":[811],"inhibition.":[815,859],"Interestingly,":[816],"impact":[818],"activated":[820],"on":[822,946],"T-cell":[824],"mediated":[825],"anti-tumour":[826],"characterized":[831],"mouse":[834],"(Carretero":[836],"2015).":[839],"Alternatively,":[840],"could":[842],"merely":[843],"surrogate":[846],"certain":[850],"type":[851],"microenvironment":[854],"susceptible":[855],"Despite":[860],"small":[862],"patient":[863],"cohort,":[864],"robustly":[869],"discriminates":[870],"three":[871],"group":[881,893],"tend":[882,894],"stay":[884,1018],"long":[886],"remission":[887],"high-risk":[892],"progress":[896],"quickly":[897],"despite":[898],"initially":[899],"often":[900],"achieving":[901],"good":[903],"response.":[904,914],"tends":[907],"better":[911],"than":[912],"validation":[916],"antibodies":[924],"separate,":[927],"larger":[928],"cohort":[929],"determination":[933],"optimal":[935],"warranted":[939],"before":[940,1133],"clinical":[941,1057],"decisions":[942],"based":[945],"use":[950],"readily":[952],"might":[955,991],"allow":[956],"early":[957],"recognition":[958],"non-responding":[960],"order":[963],"treat":[965],"predicted":[968],"poorer":[969],"outcomes":[970],"alternative":[972],"regimens":[973],"up-front":[975],"combination":[976,1000],"treatments.":[977],"Moreover,":[978],"further":[979],"investigation":[980],"possible":[983],"mechanistic":[984],"pave":[992],"way":[994],"rational":[997],"design":[998],"approaches.":[1001],"I.H.":[1002],"EHA":[1005],"grant":[1006],"\u2013":[1007],"Junior":[1008],"Short":[1009],"Term":[1010],"Collaboration":[1011],"Award":[1012],"year":[1014],"2016,":[1015],"support":[1017,1093,1158,1166,1185],"work":[1020],"guest":[1023],"researcher":[1024],"Cologne,":[1026],"Germany,":[1027],"German":[1030],"Study":[1032],"Group.":[1033],"S.B.":[1034,1098],"funding":[1036,1147,1201],"from":[1037,1052,1159,1167,1171,1175,1178,1186,1192,1202],"Cologne":[1039],"Fortune":[1040],"Grant":[1041],"(Reference:":[1042],"181/2016).":[1043],"Data":[1044],"part":[1050],"collected":[1051,1118,1123],"trial":[1058,1071],"(NCT02181738),":[1059],"approval":[1061],"sponsor":[1064,1068],"Bristol-Myers":[1065,1149,1187,1194,1204],"Sqibb.":[1066],"financed":[1069,1077],"thus":[1073],"indirectly":[1074],"partly":[1076],"collection":[1079],"but":[1080],"directly":[1083],"involved":[1084],"present":[1087],"did":[1090],"financially":[1092],"it.":[1094],"I.H.,":[1095],"S.S.":[1096],"designed":[1099],"research,":[1101],"analysed":[1102,1120,1125],"interpreted":[1104],"wrote":[1107],"manuscript.":[1109],"S.S.,":[1110],"B.v.T.,":[1111],"P.J.B.":[1112],"A.E.":[1114],"provided":[1115],"data.":[1121,1126],"J.M.":[1122],"authors":[1128,1210],"critically":[1129],"reviewed":[1130],"manuscript":[1132],"submission.":[1134],"PJB":[1135],"declares":[1136,1152,1190],"advisory":[1138],"Millennium":[1141],"Takeda":[1142,1198],"honoraria":[1144,1191],"research":[1146,1200],"Squibb.":[1150,1188],"BvT":[1151],"grants,":[1153,1161],"personal":[1154,1162,1169,1173],"fees,":[1155,1163],"non-financial":[1157,1165,1184],"Novartis;":[1160],"Takeda;":[1168],"fees":[1170,1174],"Amgen;":[1172],"Celgene;":[1176],"grants":[1177],"Merck":[1179],"&":[1180],"Co.,":[1181],"Inc.":[1182],"AE":[1189],"Affimed,":[1193,1203],"Squibb,":[1195],"Novartis":[1196],"Squibb":[1205],"Takeda.":[1207],"remaining":[1209],"declare":[1211],"no":[1212],"conflict":[1213],"interest.":[1215]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2017-05-05T00:00:00"}